Dr.Reddy’s: Outperforms industry again - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Dr.Reddy’s: Outperforms industry again

Oct 17, 2000

Dr. Reddy’s Laboratories (DRL) announced a 46% growth in the turnover for the second quarter of the current year. (This does not include the numbers for Cheminor Drugs, which is slated to be merged with the company in the current year. The merger ratio has been fixed at 9 shares of Dr. Reddy’s for every 25 shares of Cheminor.) The full results are slated to be announced on October 30th 2000. Of the total turnover of Rs 1,135.7 m, 68% is accounted by finished dosages, 30% by bulk actives and the balance by diagnostics. The first half turnover amounts to Rs 3,039.69 m, which implies a growth of 25%. This is nearly double the industry growth of around 13% in the current year.

We project a turnover of Rs 8,658 m in the current year (which includes the numbers of Cheminor and American Remedies) and an EPS in the range of Rs 35 for the full year FY2001. The current price of Rs 1,380 implies an earning multiple of 39.4 times on the full year earnings. There seems to be no dramatic undervlaution at this stage unless the company were to announce a major R & D breakthrough.

Equitymaster requests your view! Post a comment on "Dr.Reddy’s: Outperforms industry again". Click here!

  

More Views on News

Dr Reddy's New Covid-19 Treatment Option Puts Stock in Focus (Views On News)

May 24, 2021

With the second wave pushing up sales of medicines, Indian pharma companies are likely to see traction in their volumes.

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

Points to Keep in Mind Before Subscribing to Krishna Institute of Medical Sciences' IPO (Views On News)

Jun 15, 2021

All you need to know about the IPO of Krishna Institute of Medical Sciences.

Why Did Shares of Divi's Lab Rally Today? (Views On News)

Jun 10, 2021

The stock jumped 3.6% in intraday trade to hit its 52-week high.

Laurus Labs Hits New Life High. Up 500%+ in One Year (Views On News)

Jun 8, 2021

Laurus Labs trades higher for the eight straight day, soars 73% in 3 months.

More Views on News

Most Popular

Hotel Stocks Will Reward Investors (Fast Profits Daily)

Jun 8, 2021

This is why I'm bullish on the hotel and hospitality sector.

My 'Unlock' Investments (Fast Profits Daily)

Jun 11, 2021

The best unlock investments you can make in the market.

The Most Visible Sign of India's Revival is on Two Wheels (Profit Hunter)

Jun 9, 2021

Investing in the best stocks could result in wealth compounding on a massive scale.

How I Discovered a 400-Year-Old Open Secret to Extreme Wealth (Profit Hunter)

Jun 11, 2021

Charlie Munger's open secret about investing success.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Jun 17, 2021 10:35 AM

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB - NEULAND LABS COMPARISON

COMPARE DR. REDDYS LAB WITH

MARKET STATS